Immuno-positron emission tomography (immunoPET) is a paradigm-shifting molecular
imaging modality combining the superior targeting specificity of monoclonal antibody (mAb) …

Malignant pleural effusions (MPE) are a common pathology, treated by respiratory
physicians and thoracic surgeons alike. In recent years, several well-designed randomized …

Refer all patients with a chest X-ray suggestive of MPM urgently (via the 2-week wait
suspected cancer pathway in England and Wales). Consider referral for further investigation …

Guidelines for the diagnosis and treatment of malignant pleural mesothelioma - PMC Back to
Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …

Purpose Mesothelin is currently considered the best available serum biomarker of malignant
pleural mesothelioma. To examine the diagnostic accuracy and use of serum mesothelin in …

Purpose: Mesothelin (MSLN) is a tumor-associated antigen, being investigated as a
biomarker and therapeutic target in malignant pleural mesothelioma (MPM). The biologic …

Purpose: Malignant pleural mesothelioma (MPM) is an aggressive cancer associated with
poor prognosis. CRS-207 is a live-attenuated Listeria monocytogenes engineered to …

Malignant pleural mesothelioma (MPM) is a rare and aggressive cancer that arises from the
mesothelial surface of the pleural and peritoneal cavities, the pericardium, and rarely, the …

Mesothelin is a cell-surface glycoprotein present on mesothelial cells and elicits T cell
responses in a variety of cancers including pancreatic, biliary and ovarian cancer. Breast …

Simple Summary Mesothelioma is a cancer of the lining of the lungs caused by breathing in
asbestos fibres. Asbestos was widely used in industry in the last century in most developed …